DART: "Sivextro® in Acute Bacterial Skin anD Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global ObseRvational STudy."
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary) ; Tedizolid (Primary) ; Tedizolid (Primary)
- Indications Abscess; Cellulitis; Erysipelas; Wound infections
- Focus Therapeutic Use
- Acronyms DART
- Sponsors Bayer
- 19 Feb 2017 Planned End Date changed from 1 Oct 2018 to 1 Feb 2019.
- 22 Jan 2017 Status changed from not yet recruiting to recruiting.
- 16 Dec 2016 New trial record